Sprint Bioscience AB's market cap is currently kr59.09M. The company's EPS TTM is kr-0.083; its P/E ratio is ―; Sprint Bioscience AB is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
